WEKO3
アイテム
Carbon Ion Radiotherapy for Bone and Soft Tissue sarcomas.
https://repo.qst.go.jp/records/54427
https://repo.qst.go.jp/records/54427dc5bbe52-1831-489e-a1e7-4b383536d102
| Item type | 会議発表論文 / Conference Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2013-12-12 | |||||
| タイトル | ||||||
| タイトル | Carbon Ion Radiotherapy for Bone and Soft Tissue sarcomas. | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_5794 | |||||
| 資源タイプ | conference paper | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Imai, Reiko
× Imai, Reiko× 今井 礼子 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Abstract A clinical trial was first initiated in 1996 to evaluate the safety and efficacy of carbon ion radiotherapy for bone and soft tissue sarcomas not suitable for surgery. As of March 2013, over 900 patients were enrolled in the clinical trials. Through a dose escalation trial and a subsequent fixed dose trial, it was revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity for patients with bone and soft tissue sarcomas that were either difficult or impossible to cure using other modalities. The most commonly treated sarcoma at NIRS was sacral chordoma, followed by axial high-grade bone and soft-tissue sarcomas. This part deals with carbon ion radiotherapy for unresectable sarcomas below C2. |
|||||
| 書誌情報 |
NIRS＆MedAustron Joint Symposium on Carbon Ion Radiotherapy p. 24-31, 発行日 2013-12 |
|||||
